Handelsbanken Fonder’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-16,400
Closed -$144K 1663
2022
Q1
$144K Hold
16,400
﹤0.01% 1668
2021
Q4
$263K Buy
16,400
+3,800
+30% +$71.5K ﹤0.01% 1645
2021
Q3
$264K Hold
12,600
﹤0.01% 1614
2021
Q2
$338K Buy
12,600
+4,100
+48% +$120K ﹤0.01% 1590
2021
Q1
$271K Buy
+8,500
New +$206K ﹤0.01% 1478

Other funds holding MGNX

Handelsbanken Fonder's MGNX Position: Q2 2022 in Review

Handelsbanken Fonder sold out of MacroGenics (MGNX) in Q2 2022, closing a stake of 16,400 shares — an estimated $144K sold.

Handelsbanken Fonder first reported a position in MGNX in Q1 2021 and held it in 5 quarters. The position peaked at $338K in Q2 2021. 133 funds tracked by Wall St. Rank hold MGNX as of Q2 2022.

  • Handelsbanken Fonder reported no remaining MacroGenics position as of Q2 2022 after selling out during the quarter.
  • Handelsbanken Fonder sold 16,400 MacroGenics shares in Q2 2022, an estimated $144K.
  • Handelsbanken Fonder first reported a position in MacroGenics in Q1 2021 and held it in 5 quarters.
  • Handelsbanken Fonder's MacroGenics position peaked at $338K in Q2 2021.
  • 133 funds tracked by Wall St. Rank held MacroGenics as of Q2 2022.

Based on Handelsbanken Fonder's 13F filing for Q2 2022, filed 3 Aug 2022.